08/13/2020
NeuroTherapia
NeuroTherapia is a Cleveland-based company focused on discovering and developing new chemical entities for the treatment of neuroinflammation. NeuroTherapia’s lead product, NTRX-07, is a small orally-available molecule that targets specific receptors whose presence increase in certain conditions, including Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), and chronic pain syndromes.